Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Phase 1 Study of Mosliciguat in Healthy, Adult Males

NCT: NCT07185321 · COMPLETED

NCT IDNCT07185321
StatusCOMPLETED
Start Date2025-06-10
Completion2025-07-13
SponsorPulmovant, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a single-center, Phase 1, open-label, 3-period, fixed-sequence study to investigate the bioavailability, absorption, metabolism, excretion and the safety of mosliciguat administered to healthy male adults.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑